Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Neuronetics, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 17th day of December, 2024.
Madryn Asset Management, LP |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Health Partners II, LP |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Health Partners II (Cayman Master), LP |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Health Advisors II, LP |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Health Advisors GP II, LLC |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Select Advisors, LP |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Select Advisors GP, LLC
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
Madryn Select Opportunities, LP |
/s/ Matthew Girandola |
Matthew Girandola |
Chief Compliance Officer |
